baber/WOPTO huggingface dataset:
Patent CA-2504440-C (CA)
Title: Uninterrupted power supply with power-factor correcting bypass mode
Inventor: TAIMELA PASI S
IPC: H02M1/42
Filed: 2003-10-27
Granted: 2013-08-20
Abstract: A power supply apparatus (100), such as an uninterruptible power supply, includes an AC input (101) configured to be coupled to an AC power source (1') and an AC output (102). The apparatus also includes an AC/DC converter circuit (110), e.g., a boost rectifier circuit, with an input coupled to the AC input (101). The apparatus further includes a DC/AC converter circuit (120), e.g., an inverter circuit, configured to be coupled between an output of the AC/DC  converter circuit (110) and the AC output (102). A bypass circuit (S1) is operative to establish a coupling between the AC input (101) to the AC output (102) in a first (e.g., bypassed) state and to interrupt the coupling in a second (e.g., on line ) state. The AC/DC converter circuit (110) is operative to control current at the AC input (101) when the bypass circuit is in the first state. For example, the AC/DC converter circuit (110) may be operative to control current at the AC input (101) to correct a power factor at the AC  input port when bypassed, such that the AC/DC converter circuit (110) may act as a line conditioner in the bypassed state.
Patent CA-2505515-C (CA)
Inventor: VAN DONGEN JACOBUS JOHANNES MARIA
IPC: C12Q1/68
Filed: 2003-11-06
Granted: 2013-08-27
Abstract: This invention relates to the field of detecting interacting molecules. The invention provides a set of a first and a second probe each probe provided with a dye allowing energy transfer at least one probe provided with a reactive group allowing juxtaposing said first and second probe. A method is provided for detecting at least two interacting molecules at the single cell level using of a set of probes according to the invention.
Patent CA-2506349-C (CA)
Title: Procede pour fabriquer une tole en acier resistant a l'abrasion et tole obtenue
Inventor: BEGUINOT JEAN
IPC: C22C38/02
Filed: 2003-11-13
Granted: 2012-04-24
Abstract: La présente invention concerne un procédé pour fabriquer une tôle en acier résistant à l'abrasion dont la composition chimique comprend, en poids: 0,24% < C < 0,35%; 0% < Si < 2%; 0% < Al < 2%; 0,5% < Si+Al < 2%; 0% < Mn < 2,5%; 0% < Ni < 5%; 0% < Cr < 5%; 0% < Mo < 1%; 0% < W < 2%; 0,1% < Mo+W/2 < 1%; 0% < B < 0,02%; 0% < Ti < 1,1%; 0% < Zr < 2,2%; 0,35% < Ti + Zr/2 < 1,1%; 0% < S < 0,15%; N < 0,03 %, le reste étant du fer et des impuretés résultant de l'élaboration, la composition chimique satisfaisant en outre les relations suivantes : 0,095% < C* = C - Ti/4 - Zr/8 + 7xN/8 et 1,05xMn + 0,54xNi +0,50xCr + 0,3x(Mo + W/2)112 + K > 1,8, avec K = 0,5 si B > 0,0005% et K = 0 si B < 0,0005%. On soumet la tôle à une trempe. On refroidit la tôle à une vitesse de refroidissement supérieure à 0,5°C/s entre une température supérieure à AC3 et une température comprise entre T = 800 - 270xC* - 90xMn - 37xNi - 70XCr - 83x(Mo + W/2) et T-50°C; puis on refroidit la tôle à une vitesse de refroidissement à coeur Vr < 1150xep-"' entre la température T et 100°C, ep = épaisseur de la tôle exprimée en mm ; on refroidit la tôle jusqu'à la température ambiante.
Patent CA-2510760-C (CA)
Title: Stimulation of in vivo production of proteins with formulation comprising leucine
Inventor: VERLAAN GEORGE
IPC: A23L1/305
Filed: 2003-12-15
Granted: 2011-09-20
Abstract: The invention relates to a formulation in the form of a pharmaceutical composition, a food product, a feed product or a dietary supplement, comprising leucine and protein in specific amounts. Consumption of a formulation according to the invention has a very positive effect on the generation of muscle tissue and is therefore particularly useful for organisms wherein an anabolic response is desired. The total amount of leucine is at least 10% based on the dry weight of the formulation, the weight ratio of leucine to other amino acids in the proteinaceous matter is between 0.2 and 0.4.
Patent CA-2512098-C (CA)
Title: Chemical treatments for fibers and wire-coated composite strands for molding fiber-reinforced thermoplastic composite articles
Inventor: WOODSIDE ANDREW B
IPC: C08J5/06
Filed: 1997-08-07
Granted: 2007-07-17
Abstract: In one general aspect, the invention involves applying a chemical treatment to fibers, such as reinforcing fibers suitable for making a composite article, so as to size and/or preimpregnate the fibers. The chemical treatment has a relatively low viscosity and is substantially solvent-free and non-radiation curable. Heat energy may be employed to lower the viscosity and improve the wetting ability of the applied treatment and/or to increase the molecular weight of, or otherwise cure, the treatment with essentially no generation of solvent vapor. The treated fibers are used to form a composite strand, which may be subsequently processed in-line or off line into a composite article having fibers disposed in a polymeric matrix. Another general aspect relates to encased composite strands, in thread or pellet form, and to wire-coating methods and apparatus for making them. The strands are moldable into fiber-reinforced thermoplasti c composite articles. Each strand is made from fibers, including reinforcing fibers and optionally fibers of a matrix material, that are impregnated with a chemical treatment so that the treatment is disposed between substantially all of the fibers.
Patent CA-2512720-C (CA)
Inventor: JOHNSON BRUCE D
IPC: E06B7/00
Filed: 2005-07-20
Granted: 2012-10-30
Abstract: The cable mechanism includes an elongated flexible cable that has one end portion adapted for being attached to a supporting structure, for example, the exterior surface of a building by a cleat or clamp, and an opposite end portion mounted to one end portion of an axially elongated stud. The stud has an axial intermediate threaded portion while the end portion opposite the mounting of the cable is polygonal in transverse cross section. Fasteners such as a nut and washer may be provided on the stud in an axially adjusted position to at least aid in supporting, for example, the lower surface of a bay window in a leveled condition while the cable is attached to a building by a clamp or cleat.
Patent CA-2517226-C (CA)
Title: Mastic monocomposant thermoplastique durcissant a l'humidite de poly-alpha-olefine a fonctionnalite silane
Inventor: WANG BING
IPC: C08F255/00
Filed: 2004-03-11
Granted: 2013-12-10
Abstract: L'invention porte sur un mastic durcissant à l'humidité comprenant: un polymère de poly-A-oléfine à fonctionnalité silane; un élastomère thermoplastique, et un agent gluogène.
Patent CA-2519145-C (CA)
Inventor: RAO ASHOK
IPC: F02C3/20
Filed: 2003-03-18
Granted: 2009-11-03
Abstract: Carbon dioxide (152) is removed following compressor (130) which compresses a mixture of compressed air (132) and recirculated exhaust gas (118~) from a gas turbine (120). The carbon dioxide depleted gas (136) is humidified (180, 114) and fed to the combustor (110).
Patent CA-2528375-C (CA)
Inventor: BEAUBIEN SYLVIE
IPC: A61K38/06
Filed: 2004-06-18
Granted: 2013-11-19
Abstract: The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: wherein R1, R2, R3, R4, R5, R6, n1, m, p Z1, Z2, and Z3 are as describe in the specification. The invention also relates to compounds of formula (I) which are antagonists of the motilin receptor and are useful in the treatment of disorders associated with this receptor and with or with motility dysfunction.
Patent CA-2530277-C (CA)
Inventor: COLLING CRAIG W
IPC: C07C7/144
Filed: 2004-07-06
Granted: 2012-08-28
Abstract: Apparatus and processes are disclosed for economical separation of fluid mixtures utilizing perm-selective membranes. Broadly, apparatus of the invention comprises a plurality of membrane modules in counter-current cascade arrenangement comprising a solid perm-selective membrane and means for controlling enthalpy of selected fluids within the apparatus. Advantageously, the membrane modules are disposed in a first product group, a second product group, and at least one intermediate group. Apparatus of the invention is particularly useful for simultaneous. recovery of a very pure permeate product, and/or a desired non-permeate stream, from fluid mixtures of two or more compounds which when subjected to appropriately altered conditions of temperature and/or pressure exhibit a bubble point.
Patent CA-2530677-C (CA)
Title: Appareil et methode pour irradier des fluides avec un rayonnement electromagnetique
Inventor: KEMP DOUGLAS ROY
IPC: A61L2/10
Filed: 2005-12-19
Granted: 2010-05-18
Abstract: Appareil et méthode d'irradiation de fluide par un rayonnement électromagnétique, servant en particulier à l'irradiation du sang ou d'autres fluides corporels par un rayonnement ultraviolet. L'appareil comprend un boîtier dans lequel sont disposés au moins une monture, conçue pour loger une source de rayonnement ultraviolet, et au moins un support, conçu pour tenir un récipient à fluide. Le boîtier est conçu pour fonctionner entre une première position, où le récipient peut être placé dans le support, et une seconde position, où le boîtier peut former une capsule. L'appareil comporte en outre un ensemble de commandes servant à alimenter la source de rayonnement ultraviolet. Au moins une partie de la surface intérieure du boîtier peut réfléchir le rayonnement ultraviolet.
Patent CA-2532213-C (CA)
Inventor: OGURA KAZUMASA
IPC: B01D53/73
Filed: 2005-04-08
Granted: 2011-01-18
Abstract: An impurity disposal system, which disposes of impurities in natural gas (or oil-associated gas) (11) into the ground, comprises an impurity removing device (13) for removing the impurities in a gas state, a compressor (15) for compressing the removed impurity gas (12) by a drive unit (14), and a drying device (18) for removing the moisture (17) in the compressed impurity gas (16), the dried compressed impurity gas (19) being disposed of into the aquifer (20).
Patent CA-2539402-C (CA)
Title: Panoramic retractable top
Inventor: MOONEY ROBERT B
IPC: B60J7/04
Filed: 2004-11-04
Granted: 2011-12-20
Abstract: A retractable roof assembly (53) is provided for a motor vehicle (10) having a rear seat (24) and spaced apart roof side frame members (30) defining a roof opening (31). The retractable roof assembly (53) includes a split rail assembly (33) having a fixed rail (34) adapted to be fixedly secured to each of the roof side frame members (30) and extending along a portion thereof, and a movable rail (40) extending rearward of the fixed rail (34) along a remaining portion of each of the roof side frame members (30). A plurality of roof panels (58, 60, 62) extends between the roof side frame members (30) and slidably engages the split rail assembly (33) for selective movement into a stacked configuration above the movable rail (40). A linkage assembly (254) is operably connected to the movable rail (40) for pivoting and articulating the movable rail (40) relative to the fixed rail (34) when the plurality of roof panels (58, 60, 62) is in the stacked configuration in order to stow the plurality of roof panels (58, 60, 62) behind the rear seat (24) of the motor vehicle (10) such that the entire roof opening (31) is exposed.
Patent CA-2548162-C (CA)
Title: Procede de stockage de cellules vero sans serum
Inventor: ALLIKMETS ENE
IPC: C12N1/04
Filed: 2004-12-10
Granted: 2013-10-29
Abstract: L'invention concerne un procédé de stockage de cellules Véro sans sérum qui prévoit une façon normalisée et logique de produire des banques de cellules fiables et stables destinées à la production de vaccins viraux. Le remplacement de substances d'origine animale par des substances d'origine végétale dans les milieux de croissance et de congélation augmente la viabilité des cellules lors de la décongélation et réduit leur délai de récupération, ce qui permet un calendrier de fabrication plus précis et des procédés plus uniformes.
Patent CA-2550598-C (CA)
Inventor: ABOUABDELLAH AHMED
IPC: C07D239/42
Filed: 2004-12-17
Granted: 2012-10-09
Abstract: Composé répondant à la formule générale (I) (voir formule I) dans laquelle m représente un nombre entier égal à 1 ou 2 ; R1 représente un groupe de type aryle ou hétéroaryle éventuellement substitué par un ou plusieurs groupes R3 ou R4 ; R2 représente un groupe de formule générale CHR5CONHR6, R3 représente un atome d'halogène ou un groupe hydroxy, cyano, nitro, C1-6-alkyle, C1-6- alcoxy, C1-6-thioalkyle, C1-6-fluoroalkyle, C1-6-fluoroalcoxy, -O--(C2-3-alkylène)-, -O-(C1-3-alkylène)-O-, C1-6-fluorothioalkyle, C3-7-cycloalkyle, C3-7,-cycloalkyle-C1-3-alkylène, pipéridinyle, benzyloxy, pipérazinyle, pyrrolidinyle, morpholinyle, phényloxy, NR7R8, NHCOR7, NHSO2R-7, COR7, CO2R7, CONR7R8, SO2R7 ou SO2NR7R8, R4 représente un groupe de type aryle ou hétéroaryle ; le ou les groupes R4 pouvant être substitués par un ou plusieurs groupes R3 identiques ou différents l'un de l'autre ; R5 représente un atome d'hydrogène ou un groupe C1-3-alkyle ; R6 représente un atome d'hydrogène ou un groupe C1-6-alkyle, C3-7-cycloalkyle ou C3-7-cycloalkyle- C1-3-alkylène ; R7 et R8 représentent, indépendamment l'un de l'autre, un atome d'hydrogène, un groupe C1-3-alkyle ou un groupe phényle; à l'état de base, de sel d'addition à un acide, d'hydrate ou de solvat. Les composés sont des inhibiteurs de l'enzyme FAAH utiles pour le traitement de la douleur, des troubles du comportement alimentaire, des pathologies neurologiques et psychiatriques.
Patent CA-2551266-C (CA)
Title: Lignee de cellules souches embryonnaires et technique de preparation de celle-ci
Inventor: ROH SUNG-IL
IPC: C12N15/877
Filed: 2004-12-30
Granted: 2011-07-26
Abstract: La présente invention concerne une lignée de cellules souches embryonnaires dérivées d'un ovocyte de transfert nucléaire préparé par le transfert du noyau d'une cellule somatique humaine dans un ovocyte humain énucléé qui peut se différencier en divers types de cellules souhaités.
Patent CA-2553901-C (CA)
Inventor: PROCHAZKA ARTHUR
IPC: A61N1/36
Filed: 2005-01-24
Granted: 2015-01-20
Abstract: The invention provides an implant for electrically stimulating a target body tissue in a subject. The implant provides a conductive pathway for a portion of electrical current flowing between surface electrodes positioned on the subject's skin and transmits that current to the target body tissue. The implant has an electrical conductor of sufficient length to extend from subcutaneous tissue located below a surface cathodic electrode to the target body tissue. The conductor has a pick-up end which forms an electrical termination having a sufficient surface area to allow a sufficient portion of the electrical current to flow through the conductor, in preference to flowing through body tissue between the surface electrodes, such that the target body tissue is stimulated. The conductor also has a stimulating end which forms an electrical termination for delivering the current to the target body tissue. A  system and method incorporating the implant are also provided.
Patent CA-2555587-C (CA)
Inventor: VAST NATHALIE
IPC: D21H21/40
Filed: 2005-02-11
Granted: 2011-12-06
Abstract: L'invention concerne un élément de sécurité plat, ayant une face recto et une face verso, et d'un format relativement petit, tel que de planchettes, comportant au moins sur l'une de ses faces au moins un motif d'authentification repéré et/ou un motif d'authentification résultant de la combinaison et/ou superposition d'un motif sur sa face recto et d'un sur sa face verso, l'un au moins desdits motif d'authentification étant au moins en partie observable en lumière transmise. Elle concerne aussi leur procédé de fabrication ainsi que les feuilles et documents de sécurité les contenant.
Patent CA-2556754-C (CA)
Inventor: PETERSEN ETHAN
IPC: A61B5/00
Filed: 2005-02-24
Granted: 2013-06-11
Abstract: An oximeter uses a sigma-delta modulator and a multi-bit ADC (54) with PWM feedback (56) enabling high precision multi-bit conversion. Demodulation is done in software, thus requiring only a single hardware path for both red and IR. Multiple capacitors are switched into the integrator (44) in the sigma-delta modulator, with different capacitors for red, IR and dark signals, thus enabling the use of the single hardware path. A switching circuit (76) at the input of the sigma-delta modulator acts as a sample and hold, controlled by the PWM feedback (56).
Patent CA-2561683-C (CA)
Title: Sytemes et procedes utilisant un systeme anticollision permettant d'ameliorer la perception du pilote
Inventor: ROWLAN STACEY R
IPC: G08G5/04
Filed: 2005-03-29
Granted: 2015-06-23
Abstract: L'invention porte sur des systèmes et des procédés destinés à un aéronef doté d'un CAS qui peuvent être utilisés pour améliorer la perception du pilote. Le CAS peut être utilisé sur un aéronef évoluant en formation pour transmettre un avis de circulation (TA) différenciable pour un aéronef intrus évoluant en formation, contrairement à un TA résultant d'un aéronef intrus n'évoluant pas en formation. Le CAS peut également fournir une pluralité d'indications de positions pour un aéronef se ravitaillant en vol, ainsi que des indications auditives sur le mode de fonctionnement en cours du CAS.
Patent CA-2566040-C (CA)
Title: Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific binding reactions
Inventor: SPINKE JUERGEN
IPC: G01N33/53
Filed: 2005-05-10
Granted: 2010-07-20
Abstract: The invention relates to a method for increasing the dynamic measuring range of test elements, especially immunological test elements, especially optically readable immunological chromatography strips, that are based on specific bonding reactions. The invention allows to displace the dynamic test range of especially immunological test elements that are based on specific binding reactions towards higher analyte concentrations without forfeiting sensitivity. For this purpose, at least two zones in or on the test element are provided and contain reagents that produce differently strong detectable signals due to different affinities to the analyte (for example in the case of antibodies that have different affinity to the analyte) or due to different principles of interaction with the analyte or with other reagents involved in the detection of the analyte (for example antibodies directed to the analyte in one zone and analyte or analyte analog in a different zone). The signals in the at least two zones are used for evaluation of the analyte concentration/signal strength correlation and used for determining the analyte by way of a suitable method (correlation).
Patent CA-2567659-C (CA)
Title: Surgical instrument having a hydraulically actuated end effector
Inventor: SHELTON FREDERICK E IV
IPC: A61B17/03
Filed: 2006-11-08
Granted: 2014-10-14
Abstract: A hydraulically actuated surgical instrument. The instrument may comprise a handle portion and a shaft. The shaft is mechanically coupled to the handle. The instrument may also include an end effector mechanically coupled to the shaft along its longitudinal axis. The end effector may comprise a surgical implement and a hydraulic device. At least a portion of the surgical implement may be translatable along a transverse axis, wherein the transverse axis is substantially perpendicular to the longitudinal axis of the shaft. Also, the hydraulic device may be positioned to be expandable toward the surgical instrument in a direction substantially parallel to the transverse axis of the shaft.
Patent CA-2573003-C (CA)
Inventor: ALMAN PAUL TAYLOR
IPC: F16K3/24
Filed: 2005-06-23
Granted: 2014-05-13
Abstract: Low distortion seat ring assemblies for use with fluid valves are disclosed.  An example seat ring assembly (300) includes a seat ring (306) having an outer circumferential surface and a shoulder (324) extending about at least a portion of the outer circumferential surface. The shoulder (324) includes a first surface configured to form a seal against a valve body (302) and a second surface substantially opposite the first surface. The seat ring assembly also includes a seat ring retainer (308) configured to be attached to the valve body (302) and to apply a force to the second surface to hold the first surface to form the seal against the valve body (302).
Patent CA-2573095-C (CA)
Title: Une methode de synchronisation de controleurs redondants pour basculement en douceur dans des conditions normales et desadaptees
Inventor: KEPHART RICHARD W
IPC: G05B23/02
Filed: 2007-01-08
Granted: 2017-03-14
Abstract: La présente invention concerne généralement des systèmes et des dispositifs de contrôle de procédé et, plus particulièrement, un appareil et une méthode de mise en uvre dune synchronisation de contrôleurs redondants pour basculement en douceur dans des conditions normales et désadaptées, aux contrôleurs redondants. Les contrôleurs redondants sont configurés pour transmettre de linformation sur létat des zones de contrôle de procédé du contrôleur primaire au contrôleur suppléant, ce qui est nécessaire pour synchroniser les contrôleurs redondants, mais qui nest pas généralement transmis aux autres dispositifs lors de lexécution des fonctions de contrôle de procédé. Les messages de synchronisation sont transmis du contrôleur primaire au contrôleur suppléant chaque fois quune des zones de contrôle exécute des fonctions de contrôle de procédé. Selon dautres aspects, les contrôleurs redondants sont configurés pour déterminer linformation sur létat au niveau du contrôleur suppléant à partir dautres informations du réseau de contrôle de procédé, pendant un basculement du contrôleur primaire, où une condition désadaptée survient entre les zones de contrôle des deux contrôleurs au cours du téléchargement des reconfigurations, et pour lancer le contrôleur suppléant au démarrage, en présence de la condition désadaptée.
Patent CA-2579094-C (CA)
Title: Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1
Inventor: FUMERO SILVANO
IPC: C07K14/47
Filed: 2005-09-05
Granted: 2014-12-02
Abstract: The present invention relates to polypeptide variants of the HMGB-1 highaffinity binding domain Box-A (HMGB1 Box-A) or to a biologically active fragment of HMGB1 Box-A, which are obtained through systematic mutations of single amino acids of the wild-type HMGB1 Box-A protein and which show an increased resistance to proteases and which are therefore characterized by more favourable pharmacokinetic and pharmacodynamic profiles. Moreover, the present invention concerns the use of said polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1.
Patent CA-2581860-C (CA)
Inventor: BERGLUND ROGER
IPC: B22F/
Filed: 2005-10-06
Granted: 2012-11-27
Abstract: A method of reducing the oxygen content of a powder is provided. A canister is prepared with a getter, filled with the powder to be densified, sealed and evacuated. The canister is subjected to a hydrogen atmosphere at an elevated temperature whereby hydrogen diffuses into the canister through the walls thereof. The hydroge forms moisture when reacted with the oxygen of the powder and the moisture in the reacted with the getter in order to remove oxygen from the powder to the getter. The atmosphere outside the canister is then altered to an inert atmosphere or vacuum, whereby hydrogen diffuses out of the canister. A dense body having a controlled amount of oxygen can thereafter be produced by conventional powder metallurgy techniques.
Patent CA-2585603-C (CA)
Title: Vehicles for ink compositions
Inventor: ODELL PETER G
IPC: C09D11/00
Filed: 2007-04-20
Granted: 2011-09-13
Abstract: Vehicles for ink compositions are disclosed. The described ink vehicles include at least one curable component, and optionally include initiating agents, colorants, non-curable components and other additives. Processes for preparing the ink vehicles and ink compositions containing the ink vehicles are also described.